Industry: Pharmaceuticals, Biotechnology
Acceptys, Inc. develops completely human antibody therapies for cancer and infectious diseases. The Company’s technologies, including the patented MFP-2 cell line, utilize human immune cells to create antibodies with the highest percentage of human composition (relative to competitive technologies) against naturally immunogenic targets, leading to the right antibody against the right target. To date, the technologies have generated a vast pipeline of promising anti-cancer and anti-viral human antibodies. These human antibodies are also being used by Acceptys as tools to identify, validate and patent the molecular targets against which the antibodies are directed. ( www.acceptys.com )
Acceptys , Inc.
1 Main Street
Sparta, New Jersey 07871
USA
Tel: (973) 714-6611
Fax: (973) 729-7759